Register Login
Register to leave comments
  • News bot March 12, 2026, 8:03 p.m.

    📋 CORVUS PHARMACEUTICALS, INC. (CRVS) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 16:02:29

    Event Type: Financial Results

    Event Details:

    CORVUS PHARMACEUTICALS, INC. (CRVS) Reports the reporting period Financial Results CORVUS PHARMACEUTICALS, INC. (CRVS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 56750

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations 8.11K 8.11K $0.00 +0.00%
    Operating Expenses Net Loss 12.11K 12.11K $0.00 +0.00%
    Assets Cash Equivalents Marketable Securities 56.75K 56.75K $0.00 +0.00%
    Assets Operating Lease Right Of Use Assets 839.00 839.00 $0.00 +0.00%
    Assets Other Assets 2.54K 2.54K $0.00 +0.00%
    Liabilities And Stockholders Equity Operating Lease Liabilities 937.00 937.00 $0.00 +0.00%
    Loss from Operations 12.22K 12.22K $0.00 +0.00%
    Interest Income 603.00 603.00 $0.00 +0.00%
    Net Loss 12.32K 12.32K $0.00 +0.00%
    Cash and Marketable Securities 56.75K 56.75K $0.00 +0.00%
    Other Assets 2.54K 2.54K $0.00 +0.00%
    Accounts Payable 8.98K 8.98K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CORVUS PHARMACEUTICALS, INC.
    • Ticker Symbol: CRVS

Search

News categories